Clinical Trial Update: Autologous Bone Marrow Mononuclear Cells in the Combined Treatment of Coronary Heart Disease [NA]

View source ↗

Summary

Clinical trial update on autologous bone marrow mononuclear cells used with other treatments for ischemic heart disease; study completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure Diastolic
• Ischemic Heart Disease

Drugs mentioned

• Autologous bone marrow mononuclear cells (bone marrow mononuclear cells)

Snippet

Sponsor: St. Petersburg State Pavlov Medical University | Conditions: Ischemic Heart Disease, Bone Marrow Cells | NA | Status: COMPLETED | Results posted: 2021-05-24